Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and Inspire Medical Systems (NYSE:INSP – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership.
Insider & Institutional Ownership
26.4% of Vivos Therapeutics shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 2.1% of Vivos Therapeutics shares are held by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Risk and Volatility
Vivos Therapeutics has a beta of 6.04, meaning that its stock price is 504% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Vivos Therapeutics | $17.44 million | 0.14 | -$21.17 million | ($1.90) | -0.09 |
| Inspire Medical Systems | $911.98 million | 2.31 | $145.42 million | $4.62 | 15.78 |
Inspire Medical Systems has higher revenue and earnings than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent ratings and target prices for Vivos Therapeutics and Inspire Medical Systems, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Vivos Therapeutics | 1 | 1 | 2 | 0 | 2.25 |
| Inspire Medical Systems | 3 | 11 | 3 | 2 | 2.21 |
Vivos Therapeutics presently has a consensus target price of $2.80, suggesting a potential upside of 1,481.92%. Inspire Medical Systems has a consensus target price of $66.50, suggesting a potential downside of 8.76%. Given Vivos Therapeutics’ stronger consensus rating and higher probable upside, equities research analysts clearly believe Vivos Therapeutics is more favorable than Inspire Medical Systems.
Profitability
This table compares Vivos Therapeutics and Inspire Medical Systems’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Vivos Therapeutics | -122.00% | -2,325.64% | -102.01% |
| Inspire Medical Systems | 15.03% | 8.64% | 7.45% |
Summary
Inspire Medical Systems beats Vivos Therapeutics on 12 of the 15 factors compared between the two stocks.
About Vivos Therapeutics
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.
About Inspire Medical Systems
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Receive News & Ratings for Vivos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
